[Plasminogen activators and plasminogen activator inhibitor type-1 in human endometrium].
Two types of plasminogen activator (PAs) are present in human endometrium, and their contents vary with the different phases of menstrual cycle, i.e. high in the proliferative phase and low in the secretory phase. In the present study by immunohistochemical technique, both uPA and tPA antigens were demonstrated in the stromal and glandular cells of the endometrium. In cell culture, tPA was released only from stromal cells and uPA only from glandular cells as determined by SDS-PAGE followed by fibrin overlay technique, but PA inhibitor type-1 (PAI-1) was secreted by both stromal and glandular cells. Furthermore, secretion of PAs from endometrial cells was enhanced by adding estradiol and markedly inhibited by progesterone in a dose dependent manner, while the PAI reacted just in the opposite way. The effect of the peptide hormones, hCG, GnRH, PRL, as well as cAMP in cell culture on the secretion of PAs and PAI was similar to that of estradiol, while forskolin demonstrated definitely more stimulative effect on tPA than uPA. Taking into account of the finding of the present study, it appears that, under hormonal control, a balance between PAs and PAI in the endometrium exists. The physiological roles of the PAs and PAI in the endometrium were discussed.
Chen
G A
GA
Laboratory of Reproductive Biology, Institute of Zoology, Acadamia Sinica, Beijing.
Feng
Q
Q
Zhang
L Z
LZ
Liu
Y X
YX
D000328:Adult; D004717:Endometrium / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism* / Q000502:physiology; D010960:Plasminogen Activators / Q000378:metabolism*; D011374:Progesterone / Q000494:pharmacology; D010959:Tissue Plasminogen Activator / Q000378:metabolism / Q000502:physiology; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism / Q000502:physiology
D017395:Plasminogen Activator Inhibitor 1; D011374:Progesterone; D004958:Estradiol; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator